Decongestion in patients with advanced chronic kidney disease coexisting with heart failure
Descripción general
Resumen del artículo
This review discusses current strategies for managing fluid overload in patients with both heart failure and chronic kidney disease, including dietary sodium restriction, diuretics, ultrafiltration, and emerging therapies like SGLT2 inhibitors. It highlights the importance of personalized approaches due to the complex interplay of these conditions and the varying responses to treatment.
Explícamelo como si tuviera cinco años
This paper talks about how doctors manage fluid buildup in people with both heart and kidney problems, using different medications and techniques to help them pee out extra fluid.
Posibles conflictos de intereses
C.Z. is a scientific consultant to Fresenius Medical Care Europe and the Middle East. R.G. has received research support and/or honoraria from Amgen, Anthos Therapeutics, Daiichi Sankyo, Ionis and others. The other authors declare no conflicts of interest.
Limitaciones identificadas
Explicación de la calificación
This is a comprehensive and informative review that summarizes the current understanding of fluid management in a complex patient population. It provides valuable insights into the challenges and potential solutions for decongestion in patients with both heart failure and chronic kidney disease. While it lacks specific recommendations and in-depth discussion of newer technologies, its strengths outweigh these limitations, justifying a rating of 4.
Conviene saber
Este es el análisis de Starter. Paperzilla Pro verifica cada cita, investiga los antecedentes de los autores y las fuentes de financiación, y utiliza razonamiento avanzado con IA para ofrecer información más exhaustiva.
Explorar Pro →